We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Study Shows ICD Helps Heart Failure Patients

By HospiMedica staff writers
Posted on 05 Apr 2004
A clinical trial study of heart failure patients with an implantable cardioverter defibrillator (ICD) has shown that use of the device has resulted in a statistically significant improvement in patients.

The study, called RHYTHM (resynchronization hemodynamic treatment for heart failure management), evaluated the Epic HF ICD of St. More...
Jude Medical, Inc. (St. Paul, MN, USA), which combines pacemaker therapy, defibrillation therapy, and left-heart stimulation to treat heart failure.

The primary efficacy endpoint of the study was improvement in cardiac function as measured by the maximal rate of oxygen consumption (VO2) during cardiopulmonary exercise testing. The observed improvement level for cardiac resynchronization therapy (CRT) compared to the control group was 1.93 ml/kg/min, which was statistically significant. Quality of life was also significantly improved.

"This is a significant prospective, randomized study, which adds to the growing body of evidence supporting the therapeutic effectiveness of cardiac resynchronization therapy as an adjunct to optimal medical therapy for heart failure patients,” said Eric S. Fain, M.D., senior vice president, development and clinical/regulatory affairs, for St. Jude.




Related Links:
St. Jude Medical, Inc.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Multi-Chamber Washer-Disinfector
WD 390
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.